Tudurí E, Filiputti E, Carneiro EM, Quesada I. Inhibition of Ca 2ϩ signaling and glucagon secretion in mouse pancreatic ␣-cells by extracellular ATP and purinergic receptors. Am J Physiol Endocrinol Metab 294: E952-E960, 2008. First published March 18, 2008 doi:10.1152/ajpendo.00641.2007.-Glucagon secreted from pancreatic ␣-cells plays a critical role in glycemia, mainly by hepatic glucose mobilization. In diabetic patients, an impaired control of glucagon release can worsen glucose homeostasis. Despite its importance, the mechanisms that regulate its secretion are still poorly understood. Since ␣-cells are particularly sensitive to neural and paracrine factors, in this report we studied the role of purinergic receptors and extracellular ATP, which can be released from nerve terminals and ␤-cell secretory granules. Using immunocytochemistry, we identified in ␣-cells the P2 receptor subtype P2Y1, as well as the P1 receptors A1 and A2A. In contrast, only P2Y1 and A1 receptors were localized in ␤-cells. To analyze the role of purinergic receptors in ␣-cell function, we studied their participation in Ca 2ϩ signaling. At low glucose concentrations, mouse ␣-cells exhibited the characteristic oscillatory Ca 2ϩ signals that lead to secretion. Application of ATP (1-10 M) abolished these oscillations or reduced their frequency in ␣-cells within intact islets and isolated in culture. ATP␥S, a nonhydrolyzable ATP derivative, indicated that the ATP effect was mainly direct rather than through ATP-hydrolytic products. Additionally, adenosine (1-10 M) was also found to reduce Ca 2ϩ signals. ATP-mediated inhibition of Ca 2ϩ signaling was accompanied by a decrease in glucagon release from intact islets in contrast to the adenosine effect. Using pharmacological agonists, we found that only P2Y1 and A2A were likely involved in the inhibitory effect on Ca 2ϩ signaling. All these findings indicate that extracellular ATP and purinergic stimulation are effective regulators of the ␣-cell function.
sors of ␣-cell secretion may be useful treating type 2 diabetic patients (10, 46) .
Despite the importance of this hormone in controlling glycemia, many important gaps remain in the understanding of ␣-cell physiology (19) . Most of the data concerning ␣-cells derive from pancreas and islet secretion studies, yet there is not much information at the cellular level. This is partly due to the scarcity of this cell type in the islet, the lack of identification patterns, and also the technical limitations of conventional methods. In recent years, novel technical approaches based on imaging and electrophysiology have allowed further studies (15, 33, 38, 45) of ␣-cell function, especially within the intact islet, a study model the behavior of which is closer to the physiological scenario compared with isolated islet cells or cell lines. Electrical activity, Ca 2ϩ signaling, and glucagon release are all stimulated with low glucose concentrations in the ␣-cell within the islet. However, these cellular events are inhibited when glucose levels rise (15, 31, 33, 38) . This inhibitory effect has been attributed to both a direct action of the sugar and to paracrine mechanisms (19, 21, 29, 31) . In this regard, several paracrine factors from ␤-cells have been revealed as potent suppressors of glucagon secretion. Although with interspecies differences, insulin, zinc, and GABA affect ␣-cells at different levels inhibiting glucagon release (13, 27, 42, 51) .
In addition to the above-mentioned paracrine signaling molecules, other extracellular messengers could also regulate ␣-cell secretion. ATP is highly accumulated in synaptic vesicles of nerve terminals within the islet (up to 10 mM) as well as in insulin secretory granules (up to 1 mM; Refs. 4, 12, 26, 30, 41) . Once released, extracellular ATP can reach concentrations of tens of micromolar or higher on the islet cells surface (23) . Additionally, ATP molecules can be converted by plasma membrane ectonucleotidases into ATP metabolites or adenosine, subsequently activating multiple purinergic receptors and inducing a plethora of effects (12) . While ATP binds to plasma membrane P2 receptors, adenosine activates P1 receptors (12, 41) . The role of these extracellular messengers in the islet of Langerhans has been emphasized by the presence of several purinergic receptors and the rich innervation within the islet (3, 7, 32) . Additionally, it has been proposed that neural ATP release could be involved in the coordination of islet function and the pulsatility of insulin release (16, 24, 44) . The regulatory effect of extracellular ATP on the electrical activity, Ca 2ϩ signals, and insulin secretion has been proven in mouse, rat, and human ␤-cells (11, 24, 36, 44) . In the case of the ␣-cell, secretion experiments with perfused rat pancreas indicated that, whereas ATP does not have a direct effect, adenosine can promote glucagon release (6, 35) . However, the effect of purinergic stimulation on ␣-cell function has not been analyzed at the cellular level. In the present study, we identify the presence of the ATP and adenosine purinergic receptors P2Y 1 , A 1 , and A 2A in mouse ␣-cells, as well as indicate their possible function. We demonstrate that extracellular ATP and adenosine are important inhibitors of Ca 2ϩ signaling in the ␣-cell and also that, unlike adenosine, ATP produces a significant suppression of glucagon release. All these results reveal a complex purinergic signaling pathway in this islet cell type and indicate an important role in the regulation of glucagon secretion, which could be of therapeutic interest in diabetes management.
MATERIALS AND METHODS
Islet isolation and probe loading. All protocols were approved by the Animal Care Committee of the Miguel Hernandez University in accordance with the Spanish regulations and laws for animal experimentation. Swiss albino OF1 mice (8-to 10-wk-old) were killed by cervical dislocation, and pancreatic islets were then isolated by collagenase digestion as described previously (33, 37, 40) . As previously reported (33, 38) , single islets were loaded with 5 M of the acetoxymethyl form of the Ca 2ϩ probe fluo 3 (Molecular Probes; Leiden, The Netherlands) for at least 1 h at room temperature in a medium containing (mM): 115 NaCl; 10 NaHCO 3; 5 KCl; 1.1 MgCl2; 1.2 NaH2PO4; 2.5 CaCl2; 25 HEPES; 1 % BSA; and 5 D-glucose, pH 7.4. All experiments were carried out at 37°C.
In some experiments, isolated islets were dispersed into single cells and clusters by enzymatic digestion in the presence of 0.05% trypsin and 0.02% EDTA for 2 min (37, 40) . Isolated cells were plated onto poly-L-lysine-treated coverslips and cultured at 37°C in RPMI 1640 (Sigma, Madrid, Spain), supplemented with 10% FCS, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, and 5.6 mM D-glucose (37, 40) . After 24 h, cells were loaded with 4 M fluo 3 for 1 h at 37°C.
Imaging Ca 2ϩ signals by confocal microscopy. For imaging experiments, islets were placed on a perfusion chamber mounted on the microscope stage and attached onto poly-L-lysine-treated coverslips for 10 min before the experiments were commenced. Islets were then perfused at a rate of 1.5 ml/min with a modified Ringer solution containing (mM): 120 NaCl, 5 KCl, 25 NaHCO 3, 1.1 MgCl2, and 2.5 CaCl2 pH 7.4, gassed with 95% O2-5% CO2. Ca 2ϩ signals were monitored in individual cells within the islets using a Zeiss LSM 510 laser confocal microscope equipped with a ϫ40 oil immersion objective (numerical aperture ϭ 1.3). The system configuration was set to excite the Ca 2ϩ probe at 488 nm and collect the emission with a bandpass filter at 505-530 nm from an optical section of 8 m.
Images were collected at 2-s intervals. Temporal series were treated with a low pass filter and processed using the digital image software of the confocal microscope (33, 38, 39) . Individual cells loaded with fluo 3 were easily identified at the periphery of the islet (see Fig. 2A ). It has been previously reported (33, 38, 39) in islets as well as in other specimens that the fluorescent probes have difficulties penetrating the center of thick samples. However, this is not a problem since all the cell types are represented in the peripheral layers of the islet (5, 33, 39, 43) . Pancreatic ␣-cells were functionally identified by their characteristic oscillatory Ca 2ϩ signal at low glucose concentrations (2, 31, 33, 38, 39, 42, 47) . In culture experiments, single ␣-cells were further identified by their response to epinephrine (18, 29) .
Statistical analysis and data representation of Ca 2ϩ records. Fluorescence records were represented as the percentage of ⌬F/F0, where F0 is the fluorescence signal at the beginning of a record and ⌬F is FϪF0. Background fluorescence was subtracted from F0. The frequency of oscillatory Ca 2ϩ signals was calculated over a 5-min period of the Ca 2ϩ record, immediately before and 5 min after the application of the stimulus. The effect of the stimulus on frequency was calculated 5 min after its application to allow its diffusion via the perfusion system and equilibration in the cell chamber. To analyze frequency, a Ca 2ϩ oscillation or spike was defined as a rapid increase in intracellular Ca 2ϩ concentration higher than twice the standard deviation of the background signal at the intervals between spikes (33, 40, 43) . Some data were also expressed in percentages with respect to the frequency before the stimulus. Although in some cells purinergic stimulation also produced a decrease in the Ca 2ϩ signal amplitude, this parameter was not as consistent as the change in frequency. Additionally, Ca 2ϩ signal amplitude cannot be measured reliably with one-wavelength measurements due to potential artifacts such as probe photobleaching or dye leakage. Some data are shown as means Ϯ SE. Student's t-test was performed with commercial software (SigmaPlot, Jandel, San Rafael, CA).
Glucagon secretion. Batches of 15 islets were preincubated for 60 min at 37°C in 0.5 ml of Krebs-Ringer bicarbonate buffer supplemented with 15 mM HEPES, 0.5% BSA, and 5.6 mM glucose, pH 7.4 (25) . Then, islets were incubated at 37°C for 60 min with KrebsRinger bicarbonate buffer supplemented with 0.5 mM glucose and additional reagents as indicated in RESULTS (see Figs. 3 and 4) . At the end of the incubation, the medium was aspirated and assayed for glucagon using a commercial radioimmunoassay kit (GL-32K; Linco Research, St. Charles, MO). Glucagon release from intact islets was represented as described previously (25) .
Immunocytochemistry. Isolated cells were plated onto poly-L-lysinetreated coverslips and cultured at 37°C for 4 h. Then, cells were washed with PBS and fixed with Bouin's solution for 5 min. After being washed with PBS, they were dehydrated for 3 min with 30, 50, and 70% ethanol. Then, cells were permeabilized with 0.5% Triton X-100 and washed again with PBS. To reduce nonspecific antibody binding, cells were first preincubated with a blocking buffer (5% rabbit and donkey serum in PBS) for 45 min at room temperature before application of primary antibodies in a buffer containing 1% rabbit and donkey serum. For the identification of ␣-and ␤-cells, we used monoclonal antibodies anti-insulin or anti-glucagon (1:200 dilution; Sigma). For the identification of the different receptor subtypes, we used polyclonal goat antibodies anti-A 1, anti-A2A, or anti-P2Y1 (1:100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). All these antibodies were applied overnight at 4°C. After being washed, secondary antibodies conjugated with Alexa fluor dyes (Molecular Probes, Leiden, The Netherlands) were applied for 2 h at room temperature in a buffer containing 1% rabbit and donkey serum. A rabbit anti-mouse antibody (1:500 dilution; Alexa fluor 546) was used for insulin or glucagon, and a donkey anti-goat antibody (1:500 dilution; Alexa fluor 488) was used for purinergic receptors. Images were acquired using the same confocal system with an optical section of 4 m. The omission of the first antibody led to the absence of staining in all the cases. To prove the specificity of antibodies against purinergic receptors, different blocking peptides were used in control experiments (Supplemental Fig. S1 ; supplemental data for this article is available online at the Am J Physiol Endocrinol Metab website.). The reference of these peptides according to the manufacturer was sc-15204 P, sc-7500 P, and sc-7504 P for the goat antibodies anti-P2Y 1, A1, and A2A, respectively (Santa Cruz Biotechnology). Before the staining protocol, antibodies were preincubated alone (control) or with an excess of blocking peptides. The incubation was overnight at 4°C. After that, staining protocols were developed side-by-side with the control and blocked antibodies in cultures of isolated islet cells as mentioned above.
RESULTS
Multiple purinergic receptors coexist in the ␣-cell. Among the extensive group of purinergic receptor subtypes described so far (12, 41) , there is evidence that P2Y 1 , A 1 , and A 2A receptors may modulate islet function and/or glucagon release (6, 17, 35, 36) . However, the existence of these three receptors at the protein level and their cellular location have not been provided. To study the presence of these receptors in the ␣-cell, we analyzed cultures of isolated islet cells by immunocytochemistry and confocal microcopy (Fig. 1) . Identification of the P2 receptor subtype P2Y 1 and the P1 receptors A 1 and A 2A was all demonstrated in glucagon-containing cells (Fig. 1A) . As for ␤-cells, only P2Y 1 and A 1 but not A 2A receptors were identified (Fig. 1B) in agreement with previous pharmacological studies on ␤-cell function (1, 17, 35, 36) . To prove the specificity of this staining, we performed a control experiment using blocking peptides for the antibodies against purinergic receptors (Supplemental Fig. S1 ). This procedure resulted in a marked decrease of the staining intensity, indicating that cell labeling was highly specific. Additionally, further experiments with different antibodies gave similar results about the presence of these purinergic receptor subtypes in the ␣-cell (Supplemental Fig. S2) .
Extracellular ATP and adenosine inhibit Ca 2ϩ signaling in ␣-cells. To analyze the role of purinergic receptors in ␣-cell function, we first studied their involvement in Ca 2ϩ signaling. Pancreatic ␣-cells exhibit electrical activity at low glucose concentrations, which triggers oscillatory Ca 2ϩ signals that lead to glucagon secretion (15, 31, 33, 38) . Actually, it has been reported in both isolated cells and mouse intact islets that ␣-cells are the only islet cell population that exhibits Ca 2ϩ oscillations at low glucose levels (Ͻ1 mM; Refs. 2, 31, 33, 39, 42, 47) . To monitor these Ca 2ϩ signals in individual ␣-cells within intact islets, we used confocal microscopy. In Fig. 2A , we show an optical section (ϳ8 m) of an islet loaded with the Ca 2ϩ -sensitive fluorescent probe fluo 3. As previously reported (5, 33, 38, 39) , even though only the periphery of the islet was loaded, all the different cell types are represented in the outer cell layers of the mouse islet and, in particular, the ␣-cell population. At 0.5 mM glucose, several cells displayed the characteristic ␣-cell Ca 2ϩ pattern with a frequency of ϳ1 oscillation/min (33, 38, 43) . Application of ATP (10 M), the endogenous ligand for P2 purinergic receptors, rapidly reduced the frequency of oscillations or completely blocked the Ca 2ϩ signals in Ͼ95% of these cells (Fig. 2 , B and E; Table 1 ). As observed in Fig. 2F , ATP reduced the average frequency of Ca 2ϩ signals at 0.5 mM glucose to 40.5 Ϯ 10.1%. This blocking effect ceased upon removal of ATP from the medium (n ϭ 6; Supplemental Fig. S3 ). At lower concentrations (1 M), ATP decreased the frequency to 53.34 Ϯ 11.74% (Fig.  2, C, E, and F) . Given that extracellular ATP may be hydrolyzed by cell membrane ectonucleotidases into adenosine or other ATP metabolites, we used the nonhydrolyzable ATP derivative ATP␥S (22) to test if ATP action on Ca 2ϩ signals was direct or mediated by ATP hydrolytic products. Application of 10 M ATP␥S also produced an inhibitory action (Fig.  2E) . Although the effect of ATP␥S was moderately smaller than that of 10 M ATP (Fig. 2F) , this difference was not found to be statistically significant. Thus, these results indicated that ATP action on Ca 2ϩ signaling was mainly direct. Additionally, ATP (10 M) failed to inhibit Ca 2ϩ signals in the presence of suramin (100 M), an antagonist of P2 receptors (14; Fig. 2E and F) , further suggesting that ATP was principally acting through P2 receptors and not via adenosinesensitive P1 receptors due to ATP hydrolysis. In any case, since A 1 and A 2A receptors were identified in the ␣-cell (Fig.  1 ) and adenosine is a potent suppressor of ␤-cell secretion (1), we also analyzed the effect of this endogenous ligand of P1 receptors. As shown in Fig. 2D -F, the application of adenosine (10 and 1 M) also inhibited Ca 2ϩ signals. These experiments demonstrate that ATP and adenosine, the endogenous ligands of P2 and P1 receptors, respectively, can regulate Ca 2ϩ signaling in ␣-cells at physiological concentrations (23) .
Effect of ATP and adenosine on glucagon secretion. Given that ␣-cell exocytosis is Ca 2ϩ dependent (18 -21) , the blocking action of ATP and adenosine on ␣-cell Ca 2ϩ signals should be reflected in glucagon secretion. As expected, ATP (10 M), the natural agonist of P2 receptors, led to a reduction in glucagon release compared with 0.5 mM glucose (Fig. 3A) . The effect of ATP was comparable with that produced by 10 and 20 mM glucose. The action of glucose at these concentrations is mainly mediated by inhibition of Ca 2ϩ signaling in mouse ␣-cells (21, 31) . The effect of cobalt was also tested. This general blocker of voltage-gated Ca 2ϩ channels decreased glucagon release at levels similar to those previously reported in mouse islets (21) . Surprisingly, glucagon levels in the presence of adenosine were in the range of 0.5 mM glucose or slightly higher (nonsignificant, Fig. 3, A and B) . It has been reported (4, 6, 35) in rat that adenosine potentiates glucagon secretion through A 2 receptors, which are coupled to adenylate cyclase activation. Since Ca 2ϩ -dependent exocytosis in ␣-cells is highly modulated by the cAMP/PKA pathway (18, 19) , we tested the possibility that adenosine could affect glucagon secretion through this biochemical route. In agreement with this, glucagon levels in the presence of adenosine were reduced by the PKA inhibitor H-89 (Fig. 3B) . H-89 does not affect glucagon release at 0.5 mM glucose (Supplemental Fig. S4 ).
The next experiments illustrated in Fig. 4 signaling. In addition to the identification of P2Y 1 , A 1 , and A 2A receptors in the pancreatic ␣-cell, we investigated whether these receptors were functional and if they were involved in the effect of ATP and adenosine on Ca 2ϩ signaling. Although pharmacological tools are not very selective with purinergic signaling (12, 41), we used some agonists with higher affinity for the receptors identified by immunocytochemistry. ADP␤S has been previously used in ␤-cells and other cell types to characterize the P2Y 1 receptor due to its major affinity for this receptor with respect to other subtypes (12, 35, 49) . 2-Chloro-N6-cyclopentyl adenosine (CCPA) and CGS-21680 are relatively selective agonists for A 1 and A 2A receptors, respectively (12, 41) . As shown in Fig. 4, A and B , both ADP␤S and CGS-21680 produced a reduction in the frequency of Ca 2ϩ oscillations. Although they were not as efficient as the endog- Four to nine islets were used in each experiment.
enous ligands ATP or adenosine, both pharmacological agonists mimicked the inhibitory effect (Fig. 4, D and E) . On the contrary, CCPA had no significant effect on Ca 2ϩ signals (Fig.  4, C-E) . Therefore, we show that, unlike A 1 receptors, P2Y 1 and A 2A receptors may be functional in ␣-cells and involved in the regulation of Ca 2ϩ signaling. Since adenosine exhibited a different effect on Ca 2ϩ signals and secretion, we also tested the effect of CGS-21680 on glucagon release. As shown in Fig.  4F , activation of A 2A receptors by CGS-21680 stimulated glucagon secretion at 0.5 mM glucose, which points to a dual action as well.
Purinergic stimulation directly regulates ␣-cells. The presence of purinergic receptors in the ␣-cell and their involvement in Ca 2ϩ signaling (Figs. 1 and 4) supported the idea that ATP and adenosine act directly on ␣-cells rather than through paracrine mechanisms. Additionally, it has been demonstrated that both extracellular ATP and adenosine inhibit ␤-cell secretion in mouse islets (1, 6, 22, 36) . In the case of ATP, this effect results from a strong interaction with the exocytotic machinery and occurs independently of the generation of a Ca 2ϩ transient (36) . Thus, the ATP and adenosine actions on ␣-cell Ca 2ϩ signals should not be due to a ␤-cell paracrine mechanism. Regardless of this ATP blocking effect on the ␤-cell, we further inhibited its secretory response using clonidine. Although this adrenergic agonist prevents insulin secretion at different levels, particularly in the exocytotic process (8, 28, 34) , it has no effect on mouse ␣-cells (25, 50) . In the presence of clonidine, ATP (10 M) reduced the frequency of Ca 2ϩ oscillations to 53.84 Ϯ 9.93% in ␣-cells, similar to the effect obtained by ATP alone (Fig. 5, A, B, and C; Table 1 ). Finally, to further prove the direct effect on ␣-cells, we performed some experiments with cultures of single isolated cells at low densities that were perfused at high flow rates (5 ml/min). In these conditions, paracrine interactions are negligible (42) . As shown in Fig. 5D , ATP (10 M) inhibited Ca 2ϩ signals in single ␣-cells as well (n ϭ 5). Similar results were also obtained with 100 M ATP (n ϭ 5; not shown).
DISCUSSION
Control of glucose homeostasis depends on the coordinated action of glucagon and insulin secreted from pancreatic ␣-and ␤-cells, respectively (19) . An incorrect regulation of glucagon release in diabetic patients can either aggravate the hyperglycemia or can be a limitation in individuals treated with insulin (9, 10). Thus, glucagon secretion constitutes a potential target for diabetes treatment. Despite recent advances in understanding ␣-cell physiology, there are important aspects of its regulation that are still unclear (19) . At low glucose concentrations, ␣-cells develop spontaneous electrical activity, which leads to oscillatory Ca 2ϩ signals and glucagon secretion (15, 31, 33, 38) . Elevation of extracellular glucose levels inhibits all of these events. However, in addition to glucose, several studies have emphasized the significant role of neural and paracrine factors in the suppression of glucagon release (13, 27, 42, 51) . Here, we identify the presence and functional activity of P2Y 1 , A 1 and A 2A purinergic receptors in ␣-cells (Figs. 1 and 4) . We prove that extracellular ATP and adenosine potently inhibit Ca 2ϩ signals in ␣-cells (Figs. 2 and 5 ). Additionally, in contrast to adenosine, ATP was found to inhibit glucagon secretion (Fig. 3) . Thus, in addition to insulin, Zn 2ϩ , and GABA (13, 27, 42, 51) , ATP plays an important role in the inhibition of glucagon-releasing ␣-cells.
There are nineteen purinergic receptors subtypes widely distributed in various tissues, the activation of which initiates a plethora of signaling cascades and effects (12, 41) . Purinergic receptors for ATP (P2) involve ionotropic (P2X) and metabotropic (P2Y) receptors, whereas P1 receptors are adenosine specific. While ATP is released from nerve terminals and insulin-secretory granules, adenosine is mainly produced by ATP hydrolytic reactions in the extracellular space. Given that several purinergic receptor subtypes can coexist in the same cell and that current pharmacology is not selective for all these receptors, the study of purinergic signaling is complex (12) . Here, we have shown that P2Y 1 , A 1 , and A 2A are all present in the pancreatic ␣-cell (Figs. 1 and 4) . Although A 2 and P2Y 1 receptors could be involved in glucagon secretion (6, 17, 35) , the expression and localization of both receptors in the ␣-cell have not been shown previously. In any case, we do not discard the presence of other subtypes. Actually, genes encoding for P2Y 1 , P2Y 2 , P2Y 4 , and P2Y 6 have been detected in rat islets (2), while P2X 7 receptors have been identified by immunochemistry in ␣-cells from streptozotocin-diabetic rats (7). However, P2X 7 receptors are unlikely to mediate the Ca 2ϩ -signaling blockade shown here, since activation of these ionotropic receptors is coupled to extracellular Ca 2ϩ entry, which increases [Ca 2ϩ ] i (7, 12) . Activation of P2Y 1 , A 1 , and A 2A receptors triggers multiple effects in addition to the classical signaling pathways involving adenylate cyclase and phospholipase C (41) . Among other signal-transduction mechanisms, these three receptors participate in the regulation of K ϩ and voltage-gated Ca 2ϩ channels, which could affect Ca 2ϩ signals (1, 14, 36, 41) . In the pancreatic ␤-cell, extracellular ATP leads to multiple actions, including effects on the exocytotic machinery or K ATP channels and activation of phospholipase A2 and serine/threonine protein phosphatase calcineurin pathways (36) . Thus, since multiple receptors coexist in the ␣-cell, a complex purinergic signaling system may take place.
Purinergic receptors have been associated with either the activation or inhibition of Ca 2ϩ signals in multiple systems (41) . In ␤-cells, ATP triggers a Ca 2ϩ transient by release from intracellular stores (48) but at the same time induces a subsequent inhibitory effect on voltage-gated Ca 2ϩ channels in the plasma membrane, reducing Ca 2ϩ currents and allowing a negative feedback loop (14, 44) . Additionally, ATP decreases the activity of ATP-dependent K ϩ (K ATP ) channels, allowing a small depolarization in ␤-cells (36) . It has also been documented that Ca 2ϩ currents are reduced by adenosine in this cell type (1) . Given that ␣-cells exhibit Ca 2ϩ oscillations at low glucose concentrations due to the activity of both K ATP and voltage-gated Ca 2ϩ channels (15, 21), it is reasonable to suggest that purinergic stimulation could inhibit ␣-cell Ca 2ϩ signals through interaction with similar targets as those reported in ␤-cells (1, 36) . This inhibitory effect by ATP and adenosine indicates an important role of purinergic signaling in the regulation of Ca 2ϩ -dependent functions in ␣-cells. Additionally, extracellular ATP was found to be an inhibitory messenger for mouse ␣-cell secretion (Fig. 3) . A different situation has been reported in rats (17) . These discrepancies are probably due to interspecies differences, given that rat and mouse ␣-cells possess several divergences in the stimulus-secretion cou- pling and in the kind of channels involved (19) . Since ␣-cell exocytosis is a Ca 2ϩ -dependent process, the inhibitory effect of ATP on Ca 2ϩ signals (Fig. 2) should be accompanied by a decrease in glucagon secretion, as we observed with cobalt, a general Ca 2ϩ -channel blocker, and with high glucose concentrations ( Fig. 3; Ref. 21 ). In addition, ATP could also reduce glucagon release by a direct interaction with the exocytic process, as it has been shown in mouse ␤-cells (36) .
Previous studies (6, 35) with perfused rat pancreas indicated that adenosine elevates glucagon secretion at low glucose levels through the activation of A 2 receptors. In a recent study (17) with rat islets, adenosine was also found to favor glucagon release at low glucose concentrations although this effect changed at 20 mM. Our results in mice indicated that glucagon levels in the presence of adenosine were similar to those at 0.5 mM glucose (Fig. 3A) in spite of a decrease in Ca 2ϩ signaling. This dual effect may be explained by the fact that A 2A receptors are coupled to adenylate cyclase activation (4, 6, 12) . Since Ca 2ϩ -dependent exocytosis in ␣-cells is highly sensitive to activation of the cAMP/PKA pathway (18) , it is reasonable to expect that an increase in cAMP levels through A 2A receptor activation could compensate for the effect of a reduced Ca 2ϩ signal on glucagon secretion. Actually, it has been reported in ␣-cells that cAMP-elevating agents can stimulate glucagon secretion notably in conditions of reduced Ca 2ϩ currents (18, 20) . In agreement with this idea, glucagon secretion in the presence of adenosine was markedly decreased by the PKA inhibitor H-89 (Fig. 3B) . Furthermore, activation of A 2A receptors by CGS-21680 also produced a dual effect on Ca 2ϩ signaling and glucagon secretion (Fig. 4) . In this case, CGS-21680 increased glucagon secretion at 0.5 mM glucose compared with the action of adenosine. This effect probably results from the higher affinity of CGS-21680 on A 2A receptors. Although we found A 1 and A 2A receptors in the ␣-cell, the experiments shown in Fig. 4 suggested that only A 2A receptors may be functional in agreement with previous studies (6, 35) . Also, it has been indicated in other cell models that A 2A function may predominate over A 1 receptors at the adenosine concentrations used in these experiments (12). We do not discard, however, that adenosine may produce additional effects on other molecular targets.
Coexistence of P2 and P1 receptors in the same cell has been documented in multiple systems including the ␤-cell, although its functional significance is still under study (12, 35, 41) . Integration of the responses from different receptors depends on many factors, including the local concentrations of ATP and adenosine, density and affinity of receptor subtypes, and activity of plasma membrane ectonucleotidases (12, 41) . This integration can also change during pathological conditions. In our experiments, we observed that ATP affects ␣-cell secretion in contrast to adenosine (12) . In this case, the effect of ATP binding to P2 receptors may predominate over a potential action on P1 receptors induced by ATP conversion into adenosine. This idea was supported by the efficient inhibitory effect of the nonhydrolyzable ATP␥S on Ca 2ϩ signaling and the lack of ATP effect in the presence of suramin (Fig. 2, E and F) . Additionally, it has been indicated that high concentrations of ATP could inhibit several ectonucleotidases, decreasing adenosine production and then reducing the ATP effect through P1 receptors (12) . Given that ATP is highly concentrated in ␤-cell secretory granules (1-3 mM) and, especially, in synaptic vesicles of islet nerve terminals (up to 10 mM; Refs. 26, 41), its inhibitory effect on ␣-cell secretion should take place in physiological conditions. Actually, neural ATP has been proposed as a key signal responsible for the coordination of ␤-cell function (17, 24, 44) . On the other hand, the effect of adenosine binding to P1 receptors may have a role in pathological situations, since during energy-deficient states such as hypoxia, ischemia, and fasting, adenosine is released from tissues, increasing its plasma levels (35) .
The mechanisms that regulate glucagon secretion are still poorly understood. Here we demonstrate that extracellular ATP is an important inhibitor of ␣-cell function and glucagon secretion. Given that the control of the suppression of glucagon release could be important for the treatment of hyperglycemia in diabetic patients (9, 10, 46), purinergic signaling may also be a therapeutic target of clinical interest. (21, 50) . Controls in B and C were 0.5 mM glucose or 0.5 mM glucose plus clonidine (1 M). Data in B and C are means Ϯ SE. In C, effects of ATP and ATP plus clonidine were not found different (P Ͼ 0.05). *Statistically significant (P Ͻ 0.05) compared with controls.
